New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publis-hes peer-reviewed basic research papers, autho-ritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full di-versity of current biotechnology science, particu-larly those advances in research and practice that open opportunities for exploitation of knowled-ge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international.
The scope of the journal includes the research, industrial and commercial aspects of biotechno-logy, in areas such as: Healthcare and Pharma-ceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environ-ment and Biodiversity; Biocatalysis; Bioremedia-tion; Process engineering.
The journal takes a scientific approach to non-scientific issues, and also comments on matters of safety, regulation, international relations, pu-blic perceptions, ethical and societal aspects, education, and research funding.